Personalized medicine of non-gene-specific chemotherapies for non-small cell lung cancer
Non-small cell lung cancer is recognized as the deadliest cancer across the globe. In some areas, it is more common in women than even breast and cervical cancer. Its rise, vaulted by smoking habits and increasing air pollution, has garnered much attention and resource in the medical field. The firs...
Saved in:
Main Authors: | Wenxiao Jiang (Author), Guiqing Cai (Author), Peter Hu (Author), Yue Wang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Personalized medicine in non-small cell lung cancer: a review from a pharmacogenomics perspective
by: Wenxiao Jiang, et al.
Published: (2018) -
KRAS and the Reality of Personalized Medicine in Non-Small Cell Lung Cancer
by: Havva O Kilgoz, et al.
Published: (2016) -
Personalized medicine and treatment approaches in non-small-cell lung carcinoma
by: Vadakara J, et al.
Published: (2012) -
COMBINED TREATMENT OF PATIENTS WITH NON-SMALL CELL LUNG CANCER WITH PERSONALIZED PRESCRIPTION OF ADJUVANT CHEMOTHERAPY
by: E.O. RODIONOV, et al.
Published: (2019) -
The cost-effectiveness of cemiplimab plus chemotherapy as the first-line treatment for advanced non-small cell lung cancer
by: Tingting Lu, et al.
Published: (2023)